Shan Cai

Shan Cai

Auto-generated profile, based on publicly available information

Shan Cai

Centre for Medical Image Science and Visualisation (CMIV), Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2026 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
SCShan Cai
Shan Cai
CSChristian Simonsson
Christian Simonsson
MKMarkus Karlsson
Markus Karlsson
WBWile Balkhed
Wile Balkhed
JTJens Tellman
Jens Tellman
PLPeter Lundberg
Peter Lundberg
Background: Three‐dimensional (3D) MR elastography (MRE) derives viscoelastic parameters that may reflect inflammation, but their frequency dependence and the influence of steatosis on inflammation grading and fibrosis staging remain unclear. Purpose: To investigate 3D multifrequency MRE for assessing hepatic inflammation, fibrosis stage across frequencies, and the influence of steatosis. Study Type: Prospective. Population: Sixty‐four (40 men, median age: 58 years) participants with chronic liver disease (CLD); 21 (8 men, median age: 28 years) healthy volunteers. Field Strength/Sequence: 3‐T; gradient‐echo sequence with mechanical vibrations at low (16.7 and 18 Hz), medium (33.4 and 36 Hz), and high (50.1 and 54 Hz) frequencies. Assessment: In CLD participants, MRE‐derived viscoelastic parameters, shear stiffness, storage modulus, loss modulus, and damping ratio were compared with histologically assessed fibrosis, inflammation, and steatosis. MRE test–retest repeatability over 10 min was evaluated in healthy volunteers. Statistical Tests: Wilcoxon rank sum test, Spearman's correlation, multivariable regression analysis, and area under the receiver operating curve (AUROC). A p value of < 0.05 was considered statistically significant. Results: Inflammation was significantly independently associated with damping ratio at medium frequency, which showed moderate performance for grading inflammation (AUROC = 0.76–0.83, sensitivity = 0.83–0.84, specificity = 0.70–0.79). Fibrosis staging using shear stiffness and moduli showed high diagnostic performance (AUROC = 0.82–0.95), with comparable accuracy between medium and high frequencies ( p = 0.327–0.896). Steatosis was not significantly correlated with MRE overall ( p = 0.212–0.459), but was significantly associated with 19% higher stiffness and 20% higher loss modulus at medium frequency in CLD participants without fibrosis or inflammation. Data Conclusion: Medium frequency 3D MRE demonstrated an independent association with inflammation while preserving accurate fibrosis assessment. Steatosis seemed not to confound MRE‐based evaluation. Level of Evidence: 1. Technical Efficacy: Stage 2.

13 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
CSChristian Simonsson
Christian Simonsson
WBWolf Claus Bartholomä
Wolf Claus Bartholomä
ALAnna Lindhoff Larsson
Anna Lindhoff Larsson
MKMarkus Karlsson
Markus Karlsson
SCShan Cai
Shan Cai
PLPeter Lundberg
Peter Lundberg
Background & Aims: For a range of liver malignancies, the only curative treatment option may be hepatectomy, which may have fatal complications. Therefore, an unbiased pre-operative risk assessment is vital, however, at present the assessment is typically based on global liver function only. Magnetic resonance imaging (MRI) modalities have the possibility to aid this assessment, by introducing additional characterization of liver parenchymal, such as non-invasive quantification of steatosis, fibrosis, and uptake function, both for global and regional assessment. To this cause, we here present a prospective observation study (LIFE), in which patients underwent extensive MR-examinations both before and after resective-surgery. Approach and Results: A total of 13 patients undergoing hepatectomy underwent a pre- (n=13) and post (m=5) multimodal MRI examination (within 3-5 days of the surgery) (Fig. 1B). The multimodal MR-examination included DCE, 3D-MRE, fat fraction measurements (PDFF by MRS, 6PD). Using these measurements, we also construct individual patient profiles by including conventional functional, and volumetric measurements, into a multi-parametric space. As a proof of concept, the areas of each profile, denoted ‘multiparametric profile area’ (MPA, and aMPA) were calculated, to create a measurement comprising information from all modalities. At a group-level, no clear pattern emerged of MPA or aMPA between groups with different extent of resection. In contrast, on a case-by-case basis, several parameters contributed to high individual MPA or aMPA-values, suggesting tissue abnormalities. With respect to regional DCE measurements, i.e ., relative enhancement at 20 minutes, a clear variation between function in segments, within and between the individuals, was observed. Conclusions: In this combined pre- and post-observational case-based study ranging from very extensive (i) liver surgery to minor (ii), or none (iii), we aimed to describe how a multi-modal MRI examination before hepatectomy could yield valuable information for the pre-operative assessment, with a particular focus on a Couinaud-segmental level. The use of a multi-modal approach allows for a broad spectral characterization of several aspects of the remnant tissue. However, the effectiveness and clinical benefit of each parameter, and how to further optimize an abbreviated clinical MR-protocol needs to be confirmed.

18 June 2026 in European Radiology Experimental
Verified
Journal Article
Open access
WBWolf C. Bartholomä
Wolf C. Bartholomä
SCShan Cai
Shan Cai
CSChristian Simonsson
Christian Simonsson
MKMarkus Karlsson
Markus Karlsson
SKStergios Kechagias
Stergios Kechagias
PLPeter Lundberg
Peter Lundberg
Objective: Primary sclerosing cholangitis (PSC) is a rare fibroinflammatory hepatobiliary disease with a highly variable clinical course. Identifying patients at risk for poor outcomes remains challenging. Magnetic resonance imaging (MRI)-based approaches such as DiStrict, Anali score, and relative enhancement (RE) show promise but are limited by operator dependency or static measurements. This study explored pharmacokinetic modelling of liver function as a quantitative imaging biomarker for risk assessment in PSC. Materials and methods: A prospective cohort of 26 PSC patients underwent up to five annual MRI examinations with follow-up up to 7.5 years. Clinical endpoints included liver transplantation, decompensated cirrhosis, and cholangiocarcinoma. Correlation and receiver operating characteristics (ROC) analyses compared the pharmacokinetic model with Anali scores, RE, model for end-stage liver disease (MELD), and the Amsterdam–Oxford Model (AOM). Results: The pharmacokinetic model ( k single ) correlated significantly with MELD ( r = -0.429, p = 0.029), AOM ( r = -0.557, p = 0.003), and endpoint events ( r = -0.605, p = 0.001). ROC analysis showed excellent discrimination for k i,single (area under the curve [AUC] = 0.943) outperformed Anali scores (AUC = 0.800–0.829) and comparable to MELD (AUC = 0.857) and AOM (AUC = 0.900). Conclusion: Pharmacokinetic liver function modelling correlated strongly with MELD and AOM, effectively identifying high-risk PSC patients. Relevance statement: Pharmacokinetic liver function modelling detects functional impairment in PSC, correlating well with established tools such as the AOM. As an objective, quantitative imaging biomarker, this method may complement established risk scores and aid in the identification of patients at risk of adverse outcomes. Key Points: Pharmacokinetic modelling estimates changes in liver function based on MRI. These estimates can be used as a prognostic tool in PSC. The model’s prognostic performance was comparable to established clinical tests.